Skip to main content
PRGOPerrigo Company plcSell5.3·$10.22-1.83%
PRGO · Concentration risk · 10-K extracted

Perrigo Company (PRGO) concentration risks

Updated

The most significant concentration Perrigo Company discloses is single-source suppliers, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Perrigo Company’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 3 disclosed concentrations

HIGH1
MEDIUM1
LOW1
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHOutside partySupplier

single-source suppliers

10-K Item 1A: 'We maintain several single-source supplier relationships, either because alternative sources are not available or because the relationship is advantageous'
SEC 10-K · filed Feb 2026
MEDIUMOutside partyCustomer
47%

top ten customers

10-K Item 1: 'Our top ten customers accounted for 47% of our total consolidated net sales in 2025 and 2024.'
SEC 10-K · filed Feb 2026
LOWOutside partyCustomer
12.9%

Walmart Inc.

10-K Item 1: 'Sales to Walmart Inc. represented 12.9% and 11.9% of our consolidated net sales in 2025 and 2024, respectively.'
SEC 10-K · filed Feb 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-07-12

Perrigo's concentration risk spans both supply and customer channels. On the supply side, the company maintains several single-source supplier relationships, either because alternatives aren't available or because the relationship is advantageous — a high-share dependency embedded in how certain products are sourced, though no specific supplier or percentage is disclosed. On the customer side, the top ten customers accounted for 47% of total consolidated net sales in both 2025 and 2024, a stable medium-share dependency. Within that group, Walmart Inc. stands out individually, representing 12.9% of consolidated net sales in 2025, up from 11.9% in 2024 — a low-share but modestly growing single-customer exposure. Taken together, the picture is one where nearly half of sales flow through ten retail relationships, with Walmart alone and growing as the largest single thread within that group, layered on top of an unquantified but high-share reliance on sole-source suppliers for certain products. The customer-side concentration is the more trackable and increasingly relevant exposure given Walmart's rising share, while the supplier dependency is the less visible but potentially more disruptive risk if any single-source relationship were to break down.

For the engine’s reasoning on PRGO’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Drug Manufacturers - Specialty & Generic

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
ANIPANI Pharmaceuticals, Inc.2103
AMLXAmylyx Pharmaceuticals, Inc.2002
AMPHAmphastar Pharmaceuticals, Inc.1214
PRGOPerrigo Company plc1113
AMRXAmneal Pharmaceuticals, Inc.1102
ALKSAlkermes plc0112

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks PRGO Concentration risk